HOME | SITEMAP | CONTACT US









 
   
About the NCCR
Committee Members
Services & Guidelines
Good Clinical Practice (GCP)
Guideline on the Use of Human Biological Tissues for Research
Guidelines for Ethical Review of Clinical Research or Research involving human subjects
International Ethical Guidelines for Biomedical Research (CIOMS 2002)
Operational Guidelines for Ethics Committees That Review Biomedical Research (WHO 2000)
Guidelines for Application of Clinical Trial Import Licence and Clinical Trial Exemption in Malaysia
Guidelines for Good Clinical Practice (GCP) Inspection
Approved Research
Clinical Investigators
Useful Links
NCCR Bulletin
MOH News
Contact Us







  Guidelines for Application of Clinical Trial Import Licence and Clinical Trial Exemption in Malaysia



Guidelines for Application of Clinical Trial Import Licence and Clinical Trial Exemption in Malaysia (PDF, 487KB)
FOREWORD

Since the last update of the Guidelines for the Application of Clinical Trial Import License (CTIL) and Clinical Trial Exemption (CTX) in Malaysia in 2004, there has been significant changes in regulatory environment for clinical trial. Thus, it is timely and appropriate to streamline the existing guidelines in accordance with the current needs, regulatory requirements and international standards.

The significant changes in this guideline amongst others include changes in the format of the guidelines, application forms for CTIL and CTX, reporting of serious adverse events, pharmaceutical data requirements for herbal products (Annex B1), responsibility of license holders, conditions for CTIL / CTX, labelling requirements, guidance for the application of variation, processing fee for CTIL renewal and product accountability and disposal. The updated guidelines shall assist sponsors, contract research organisations (CROs), local investigators and others in their applications for CTIL/ CTX. Adherence to these updated guidelines will facilitate the CTIL/ CTX applications leading to timely approval by the Drug Control Authority.

I would like to take this opportunity to extend my deepest appreciation to all the committee members who have contributed in one way or another to making this 5th edition of the guidelines (June 2009) a reality. It is my hope that with these guidelines will further contribute towards strengthening and promoting Malaysia as a clinical trial hub in this region.

Selvaraja Seerangam
Director of Pharmacy Regulatory
National Pharmaceutical Control Bureau
Ministry of Health, Malaysia

June 2009

Guidelines for Application of Clinical Trial Import Licence and Clinical Trial Exemption in Malaysia (PDF, 487KB)

 



 Print Friendly [ Total Hits: 378338 | Page Hits: 16679 ]

 
 

This website is managed and sponsored by the Clinical Research Centre, Ministry of Health Malaysia
Copyright © 2005 - 2017 National Committee for Clinical Research (NCCR). All Rights Reserved.  
Powered by Cornerstone Content Management System